معرفی
Mark Scott Baker is an Honorary Professor at the Macquarie Medical School, Macquarie University. His research focuses on proteomics, cancer biomarkers, and translational oncology. He leads projects such as 'High content oncoproteomics for improved prognostication and treatment response' and 'uPAR interference peptide antagonists of avß6·uPAR interaction as colorectal cancer (CRC) metastasis therapy leads.'
- Research interests include proteomics, protein biomarker discovery, and mass spectrometry applications in cancer research.
- Notable collaborations involve institutions like the University of Sydney and projects funded by the ARC.
His recent work emphasizes improving cancer prognosis through proteomic analysis of plasma extracellular vesicles and developing therapeutic peptides targeting metastasis pathways. Key contributions include identifying biomarkers in stage II colorectal cancer and advancing DIA-MS methods for low-abundance protein detection.
Grants and awards include leadership in multiple ARC-funded initiatives and collaborations with industry partners. His lab's work has been cited widely, reflecting significant contributions to medical proteomics.
